tm
Seeing Is Believing
tm
Seeing Is Believing
NAMS is currently covered by 4 analysts with an average price target of $54.67. This is a potential upside of $18.95 (53.05%) from yesterday's end of day stock price of $35.72.
NewAmsterdam Pharma Company N.V. Ordinary Shares's activity chart (see below) currently has 13 price targets and 21 ratings on display. The stock rating distribution of NAMS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 70% with an average time for these price targets to be met of 345.6 days.
Highest price target for NAMS is $48, Lowest price target is $40, average price target is $45.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 12-Jun-2025. First documented stock forecast 06-Jan-2023.
Currently out of the existing stock ratings of NAMS, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$40
$4.28 (11.98%)
$36
4 months 13 days ago
(12-Jun-2025)
6/6 (100%)
$18.97 (90.20%)
306
Buy
$48
$12.28 (34.38%)
$48
9 months 11 days ago
(14-Jan-2025)
0/2 (0%)
$24.33 (102.79%)
Buy
$47
$11.28 (31.58%)
$35
10 months 14 days ago
(11-Dec-2024)
1/2 (50%)
$21.43 (83.81%)
576
Buy
$37
$1.28 (3.58%)
$37
1 years 1 months 2 days ago
(23-Sep-2024)
2/2 (100%)
$21.53 (139.17%)
508
Buy
$22
$-13.72 (-38.41%)
$21
2 years 6 months 22 days ago
(03-Apr-2023)
2/2 (100%)
$8.47 (62.60%)
338
What is NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) average time for price targets to be met?
Which analyst has the current highest performing score on NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) with a proven track record?
Which analyst has the current lower performing score on NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) with a proven track record?
Which analyst has the most public recommendations on NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares)?
Which analyst is the currently most bullish on NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares)?
Which analyst is the currently most reserved on NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares)?
